BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 32340482)

  • 21. Comparative study of renal drainage with different ureteral stents subject to extrinsic ureteral obstruction using an in vitro ureter-stent model.
    Shilo Y; Modai J; Leibovici D; Dror I; Berkowitz B
    BMC Urol; 2021 Jul; 21(1):100. PubMed ID: 34261481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periureteral Marginal Zone Lymphoma Resulting in Hydronephrosis and Flank Pain in the Absence of Disseminated Disease: Case Report of Two Patients Presenting with Rare But Important Differential.
    Whiles BB; Duchene DA
    J Endourol Case Rep; 2020; 6(4):519-522. PubMed ID: 33457718
    [No Abstract]   [Full Text] [Related]  

  • 23. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.
    Kamiyama Y; Matsuura S; Kato M; Abe Y; Takyu S; Yoshikawa K; Arai Y
    Int J Urol; 2011 May; 18(5):379-82. PubMed ID: 21518020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
    de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
    Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction.
    Nas OF; Oztepe MF; Kandemirli SG; Bilgin C; Ozkaya G; Inecikli MF; Kaygısız O
    Abdom Radiol (NY); 2021 May; 46(5):2188-2194. PubMed ID: 33226456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
    Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
    BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Matsuura H; Arase S; Hori Y
    Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
    Haas CR; Shah O; Hyams ES
    J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
    [No Abstract]   [Full Text] [Related]  

  • 29. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
    Netsch C; Becker B; Gross AJ
    Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents.
    Elsamra SE; Leavitt DA; Motato HA; Friedlander JI; Siev M; Keheila M; Hoenig DM; Smith AD; Okeke Z
    Int J Urol; 2015 Jul; 22(7):629-36. PubMed ID: 25950837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction.
    Shvero A; Haifler M; Mahmud H; Dotan Z; Winkler H; Kleinmann N
    Support Care Cancer; 2022 Nov; 30(11):9541-9548. PubMed ID: 36056940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous urinary drainage and ureteric stenting in malignant disease.
    Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.